AI Terminal
NUFORMIX PLC
Director's Dealing • Jan 31, 2022
4941_dirs_2022-01-31_427231dd-f636-4b58-b2ff-35e4381a199d.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 1883A
Nuformix PLC
31 January 2022
31 January 2022
Nuformix plc
("Nuformix" or the "the Company")
Director/PDMR Shareholding
Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, announces that it has granted a total of 3,000,000 warrants each to Dr Alastair Riddell, Dr Julian Gilbert and Maddy Kennedy with an exercise price of 1.45p per share.
- Ends -
Enquiries:
| Nuformix plc | via Walbrook | ||||
| Dr Alastair Riddell, Executive Chairman | |||||
| Allenby Capital Limited | +44 (0) 20 3328 5656 | ||||
| Nick Athanas / George Payne (Corporate Finance) | |||||
| Stefano Aquilino / Matt Butlin (Sales and Corporate Broking) | |||||
| Walbrook PR | [email protected] or +44 (0)20 7933 8780 | ||||
| Anna Dunphy / Phillip Marriage | Tel: +44 (0)7876 741 001 / +44 (0)7867 984 082 | ||||
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Dr Alastair Riddell
2
Reason for the notification
a)
Position/status
PDMR - Executive Chairman
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Nuformix plc
b)
LEI
2138003XG3H3I2J3BJ24
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Warrants to acquire ordinary shares at a price of 1.45p per share.
GB00BYW79Y38
b)
Nature of the transaction
Granting of warrants
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 0 | 3,000,000 |
d)
Aggregated information
Single Transaction
e)
Date of the transaction
31 January 2022
f)
Place of the transaction
Off-market transaction
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Dr Julian Gilbert
2
Reason for the notification
a)
Position/status
PDMR - Non-executive Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Nuformix plc
b)
LEI
2138003XG3H3I2J3BJ24
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Warrants to acquire ordinary shares at a price of 1.45p per share.
GB00BYW79Y38
b)
Nature of the transaction
Issue of warrants
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 0 | 3,000,000 |
d)
Aggregated information
Single Transaction
e)
Date of the transaction
31 January 2022
f)
Place of the transaction
Off-market transaction
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Maddy Kennedy
2
Reason for the notification
a)
Position/status
PDMR - Non-executive Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Nuformix plc
b)
LEI
2138003XG3H3I2J3BJ24
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Warrants to acquire ordinary shares at a price of 1.45p per share.
GB00BYW79Y38
b)
Nature of the transaction
Issue of Warrants
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 0 | 3,000,000 |
d)
Aggregated information
Single Transaction
e)
Date of the transaction
31 January 2022
f)
Place of the transaction
Off-market transaction
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHWPUMUGUPPGCG